MYCN and neuroblastoma: Indeed, as mentioned, AMD inhibition cooperates with ODC inhibition to block tumor initiation in the neural crest of TH-MYCN neuroblastoma-prone mice, yet it antagonizes DFMO activity in the setting of therapy for established and progressing tumors [69].